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Abstract: Entropy-based complexity of cardiovascular variability at short time scales is 
largely dependent on the noise and/or action of neural circuits operating at high 
frequencies. This study proposes a technique for canceling fast variations from 
cardiovascular variability, thus limiting the effect of these overwhelming influences on 
entropy-based complexity. The low-pass filtering approach is based on the computation of 
the fastest intrinsic mode function via empirical mode decomposition (EMD) and its 
subtraction from the original variability. Sample entropy was exploited to estimate 
complexity. The procedure was applied to heart period (HP) and QT (interval from Q-wave 
onset to T-wave end) variability derived from 24-hour Holter recordings in 14  
non-mutation carriers (NMCs) and 34 mutation carriers (MCs) subdivided into 11 
asymptomatic MCs (AMCs) and 23 symptomatic MCs (SMCs). All individuals belonged 
to the same family developing long QT syndrome type 1 (LQT1) via KCNQ1-A341V 
mutation. We found that complexity indexes computed over EMD-filtered QT variability 
differentiated AMCs from NMCs and detected the effect of beta-blocker therapy, while 
complexity indexes calculated over EMD-filtered HP variability separated AMCs from 
SMCs. The EMD-based filtering method enhanced features of the cardiovascular control 
that otherwise would have remained hidden by the dominant presence of noise and/or fast 
physiological variations, thus improving classification in LQT1. 
Keywords: heart rate variability; LQT1; EMD; sample entropy; KCNQ1-A341V mutation; 
beta-blocker therapy; autonomic nervous system; cardiovascular control 
 
1. Introduction 
Long QT syndrome type 1 (LQT1) is an inherited disease affecting the delayed slow rectifier 
potassium current IKs of the cardiac cells. The most visible effect of this pathology on the surface 
electrocardiogram is the prolongation of the QT interval accompanied by its maladjustments to heart 
period (HP) changes [1,2]. As a consequence, in the presence of a tachycardic run, LQT1 patients have 
a greater likelihood that the incoming cardiac depolarization occurs when the ventricular repolarization 
process is not concluded, and this phenomenon promotes the development of lethal arrhythmias. 
While genetic mutations underpinning LQT1 have been recognized [2] and the administration of 
beta-blockers, lengthening HP and reducing HP variability, is an effective therapy [3], the attention of 
the scientific community has recently moved towards factors modifying the arrhythmic risk of LQT1 
patients [4–7]. Indeed, within a group of mutation carriers (MCs) presenting the same genotype, two 
different phenotypes might be detected, leading to completely different clinical outcomes: 
asymptomatic MCs (AMCs), who did not develop any major cardiac arrhythmias and, thereby, are at 
low cardiac risk, and symptomatic MCs (SMCs), who experienced episodes of cardiac arrest and 
syncope and, thereby, are at high cardiac risk. Recent studies pointed out the role of the autonomic 
nervous system in modulating the cardiac risk of LQT1 patients [8,9]. Indeed, it was found that AMCs 
feature a low baroreflex sensitivity [8] and a smaller HP prolongation after an exercise stress test [9] 
compared to SMCs, thus suggesting that a less reactive vagal control directed to the sinus node is a 
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protective factor. Even more recently, we found that AMCs exhibit a lower complexity of the QT 
variability at long time scales [10], as assessed from multiscale entropy analysis [11,12], compared to 
SMCs, thus suggesting that a less complex sympathetic control directed to ventricles is a protective 
factor and stressing the clinical relevance of the assessment of complexity indexes from QT variability 
in LQT1 [10].  
Unfortunately, automatic QT measurement is a complicated task due to the difficulty in defining the 
T-wave end, especially in 24-hour Holter recordings with low temporal resolution and in pathological 
individuals exhibiting abnormal ventricular repolarization [13]. As a consequence, QT variability is 
affected by broad band noise and has a low signal-to-noise ratio, which might prevent any 
differentiation between AMCs and SMCs. As a matter of fact, multiscale entropy analysis [11,12] 
allowed the separation between AMCs and SMCs at long time scales due to its intrinsic ability to filter 
fast QT variations when long time scales are under scrutiny [10].  
The aim of this study is to provide a method to filter out fast fluctuations of QT variability and to 
allow the separation among groups having different cardiac risk using complexity analysis, even at 
short time scales, thus rendering unnecessary the application of the multiscale entropy and simplifying 
the process of LQT1 risk stratification based on complexity analysis. This method is based on the 
empirical mode decomposition (EMD) [14], allowing the decomposition of the QT variability into 
oscillatory modes, called intrinsic mode functions (IMFs), and on the evaluation of complexity at short 
time scales based on sample entropy (SampEn) [15]. EMD has been extensively applied to 
cardiovascular variabilities, especially to HP dynamics [16–18], with relevant findings in risk 
stratification of chronic heart failure patients [19]. SampEn is a widely-accepted method for the 
assessment of the complexity of the cardiac control, and it has been extensively validated compared to 
other entropy-based metrics [20,21]. We hypothesize that the fastest IMF computed over QT 
variability provides a good description of the superimposed noise. Therefore, we propose to perform 
traditional complexity analysis at short time scales using SampEn over the original QT variability after 
having canceled the fastest IMF. We applied this procedure to QT variability derived from 24-hour 
Holter recordings obtained from non-MCs (NMCs) and MCs, all belonging to a South African founder 
population with LQT1 due to the KCNQ1-A341V mutation [22,23]. The procedure was applied to the 
HP variability series, as well. We assessed the ability of the method to distinguish NMCs from MCs, 
divided into AMCs and SMCs, and to study the effect of beta-blocker therapy (BB) in AMCs and 
SMCs. The contribution of the autonomic nervous system to the original QT and HP series and their 
EMD-filtered versions were evaluated, as well, by comparing recordings obtained daytime (DAY) and 
nighttime (NIGHT) in both AMCs and SMCs. 
2. Methods 
2.1. EMD-Based Filtering Approach  
Given the time series x = {x(i), i = 1, …, N} with x = HP or QT, where i is a progressive cardiac 
beat number and N is the series length, EMD is a technique allowing the decomposition of the signal 
into IMFs from the shortest to the longest time scale [14]. IMFs are characterized by the symmetry 
with respect to zero, the uniqueness of the local frequency and the impossibility for different modes to 
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share the same frequency at the same time. The method is based on an iterative procedure composed 
by several steps: (1) the identification of all the extrema (maxima and minima) of x; (2) the generation 
of the upper and lower envelope of x via cubic spline interpolation among all maxima and minima of x, 
respectively; (3) point-by-point averaging of the two envelopes to compute the local mean series m; (4) 
subtraction of m from x to obtain a mode candidate h (i.e., h(i) = x(i) − m(i)); (5) if h did not satisfy the 
previously defined properties necessary to be an IMF, x was replaced with h and the procedure was 
repeated starting from the first step; and (6) if h did fulfill the previously defined properties to be an 
IMF, the procedure was repeated starting again from first step over the residual (i.e., the difference 
between the original x and all identified IMFs). The process ended when the amplitude of the residual 
satisfied a predefined stopping criterion (i.e., the residual was below a predetermined level, or it had a 
monotonic trend) [14]. In this work, we identified only the first IMF as being the one with the fastest 
characteristic frequency (CF), and we filtered x by subtracting the first IMF from x, thus providing an 
EMD-filtered version of the original series, xf. The CF of the first IMF was computed as the median of 
the instantaneous frequency of the first IMF obtained from the Hilbert spectrum [19]. 
2.2. SampEn 
Given x, we define the pattern of length L, xL(i) as the ordered sequence of L delayed samples,  
xL(i) = [x(i), x(i − 1), …, x(i − L + 1)]. The pattern xL(i) is actually a point in the L-dimensional 
embedding space reconstructed with the technique of the lagged coordinates with a delay equal to 1. 
The pattern xL(i) can be seen as the sequence formed by the current sample, x(i), and by the sequence 
of L-1 past samples, xL-1(i − 1) = [x(i − 1), …, x(i – L + 1)], i.e., xL(i) = [x(i), xL-1(i − 1)]. Defined as  
xL = {xL(i), i = L, …, N} and xL-1 = {xL-1(i − 1), i = L, …, N} the sets of patterns of length L and L − 1 
respectively, SampEn estimates the conditional probability that two patterns that are closer than a 
tolerance r in xL−1 remain nearby in xL [15]. It was calculated as the difference between the negative 
logarithm of the average probability of finding two patterns closer than r in L-dimensional and  
(L − 1)-dimensional embedding space [15]. SampEn was computed with r equal to 0.15-times the 
standard deviation of the series and with an embedding dimension L = 3. SampEn was assessed over x, 
labeled as SampEnx, and over xf, labeled as SampEnxf, with x = HP or QT.  
3. Study Population, Experimental Protocol and Data Analysis  
3.1. Study Population 
All NMCs and MCs belonged to a South African founder population with LQT1 due to the 
KCNQ1-A341V mutation [22,23]. Twelve-lead 24-hour Holter recordings were acquired from  
14 NMCs (aged from 19 to 56, median = 36.5; 6 males) and 34 MCs divided in 11 AMCs (aged from 
24 to 62, median = 46; 4 males) and 23 SMCs (aged from 16 to 57, median = 39; 9 males). The groups 
are age-matched according to a Kruskal-Wallis one-way analysis of variance on ranks with p < 0.05. 
Seven AMCs and 22 SMCs were recorded both off BB (BBoff) and on BB (BBon). The remaining  
4 AMCs and 1 SMCs were recorded only BBoff. All MCs were recorded BBoff. The number of 
subjects and the relevant pharmacological condition are summarized in Table 1. The administered 
drugs were quite homogeneous among patients being in 86% of the cases under propranolol therapy. 
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The protocol adhered to the principles of the Declaration of Helsinki for medical studies involving 
human subjects. The protocol was approved by the local ethical committees of the Universities of 
Vanderbilt, Stellenbosch and Pavia. All enrolled subjects and family members signed an informed 
consent for clinical and genetic evaluations. Written informed consent was obtained from the next of 
kin, caretakers or guardians on behalf of minors enrolled in the study.  
Table 1. Number of subjects undergoing a complete 24-hour Holter recording in each 




Number of subjects 
acquired only BBoff 
Number of subjects acquired both  
BBoff and BBon 
NMC 14 14 0 
AMC 11 4 7 
SMC 23 1 22 
NMC = non mutation carrier; BB = beta-blocker therapy; BBoff = off BB; BBon = on BB;  
AMC = asymptomatic MC; SMC = symptomatic MC. 
3.2. Data Acquisition 
Seventy-seven 12-lead 24-hour Holter recordings (Mortara Instrument Inc., Milwaukee, WI, USA 
and Ela Medical, Sorin Group, Arvada, CO, USA) were analyzed. The majority of the recordings were 
acquired using equipment from Mortara Instrument (i.e., 90%). The sampling rate was 180 Hz with an 
amplitude resolution of 6.25 µV for the Mortara device, while it was 200 Hz with an amplitude 
resolution of 10 µV for the Ela Medical device. The lead with the best signal-to-noise ratio was chosen 
for analysis. The availability of 24-hour Holter recordings permitted the selection of epochs of 5000 
consecutive beats during DAY (from 2:00 to 6:00 PM) and NIGHT (from 12:00 PM to 4:00 AM).  
3.3. Data Analysis 
We computed HP as the temporal distance between two consecutive R-wave peaks of the 
electrocardiogram. Jitters in the R-wave location were minimized via parabolic interpolation. Then, we 
took the time distance between the R-wave peak and the T-wave end as an approximation of the QT 
interval [24]. The end of the T-wave was located when the absolute value of the first derivative over 
the descending part of the T-wave went below a user-defined threshold computed as 30% of the 
maximum absolute value of the first derivative computed on the T-wave downslope [24]. The HP and 
QT intervals were automatically extracted from Holter recordings. Results were manually checked to 
avoid missing beats or erroneous identifications. HP and QT series were corrected through cubic spline 
interpolation only in the case of missing beats, the detection of spikes of noise or evident arrhythmias. 
The number of the corrections was always kept below 5% of the length of the series. HP and QT series 
were extracted during DAY and NIGHT. The mean of HP, QT and corrected QT (QTc) according to 
the Bazett’s formula [25] were evaluated and labeled as μHP, μQT and μQTc respectively. SampEn was 
computed over the original HP and QT series (i.e., SampEnHP and SampEnQT) and from the  
EMD-filtered HP and QT series (i.e., SampEnHPf and SampEnQTf). The CF of the first IMF derived 
from HP and QT variability was assessed, as well. 
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3.4. Statistical Analysis 
The Wilcoxon signed rank test was utilized to assess the significance of the differences between CF 
computed over the first IMF of HP and QT series regardless of group, period of analysis and therapy. 
Two-way repeated measures analysis of variance (one factor repetition, Holm-Sidak test for multiple 
comparisons) was utilized to assess the significance of the differences between SampEn assessed over 
the original and EMD-filtered HP and QT series, regardless of group, period of analysis and therapy. 
One-way analysis of variance (Holm-Sidak test for multiple comparisons), or Kruskal-Wallis one-way 
analysis of variance on ranks (Dunn’s method for multiple comparisons) when appropriate, was 
applied to check the significance of the differences among BBoff NMCs, AMCs and SMCs during 
DAY. Two-way repeated measures analysis of variance (one factor repetition, Holm-Sidak test for 
multiple comparisons) was utilized to assess the significance of the differences between BBoff AMCs 
and SMCs in relation to the period of analysis (i.e., DAY and NIGHT) and between AMCs and SMCs 
during DAY in relation to therapy (i.e., BBoff and BBon). Statistical analysis was carried out using a 
commercial statistical program (Sigmaplot, Systat Software, Inc, Chicago, IL, ver.11.0). p < 0.05 was 
always considered as significant.  
4. Results  
The mean of HP, QT and QTc (i.e., μHP, μQT, μQTc) were reported in Tables 2, 3 and 4 as mean ± 
standard deviation. μHP increased during NIGHT (Table 3) and as a consequence of BB (Table 4) in 
both AMCs and SMCs. In addition, μHP was longer in AMCs than in NMCs (Table 2), and μHP 
lengthened more in response to BB in AMCs than in SMCs (Table 4). μQT was longer in MCs (Table 
2) and it increased during NIGHT in both AMCs and SMCs (Table 3) and due to BB only in SMCs 
(Table 4). μQTc was longer in MCs (Table 2), and it decreased during NIGHT only in AMCs (Table 3) 
and due to BB in both AMCs and SMCs (Table 4). 
Table 2. Mean of HP, QT and QTc in BBoff NMCs and MCs during DAY.  
 NMC AMC SMC 
μHP (ms) 697.6 ± 100.6 847.9 ± 143.8 § 761.3 ± 95.0 
μQT (ms) 317.6 ± 39.2 422.2 ± 51.7 § 408.6 ± 42.4 § 
μQTc (ms.s−1/2) 397.1 ± 71.9 461.9 ± 33.9 § 468.7 ± 33.4 § 
§: p < 0.05 versus NMCs.  
Table 3. Mean of HP, QT and QTc in BBoff AMCs and SMCs during DAY and NIGHT. 
 DAY NIGHT 
 AMC SMC AMC SMC 
μHP (ms) 847.9 ± 143.8 761.3 ± 95.0 1,022.6 ± 136.3 * 952.4 ± 117.1 * 
μQT (ms) 422.2 ± 51.7 408.6 ± 42.4 447.5 ± 42.1 * 445.3 ± 31.2 * 
μQTc (ms.s−1/2) 461.9 ± 33.9 468.9 ± 33.4 445.0 ± 30.5 * 458.6 ± 25.4 
*: p < 0.05 within the same group (i.e., AMCs or SMCs) versus DAY.  
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Table 4. Mean of HP, QT and QTc in AMCs and SMCs both BBon and BBoff during DAY. 
 BBoff BBon 
 AMC SMC AMC SMC 
μHP (ms) 855.8 ± 143.5 757.9 ± 95.8 1,038.2 ± 176.0 @ 927.8 ± 117.2 #,@ 
μQT (ms) 424.0 ± 57.6 406.5 ± 42.1 426.7 ± 58.0 429.8 ± 29.3 @ 
μQTc (ms.s−1/2) 459.4 ± 43.0 467.5 ± 33.7 418.8 ± 37.2 @ 447.4 ± 28.1 @ 
@: p < 0.05 within the same group (i.e., AMCs or SMCs) versus BBoff. #: p < 0.05 within the same therapy (i.e., BBoff or 
BBon) versus AMCs subjects.  
Figure 1 shows the CF of the first IMF derived from the series of HP (Figure 1a,c,e) and QT  
(Figure 1b,d,f). The CF of the first IMF computed over the HP series was similar in NMCs, AMCs and 
SMCs (Figure 1a). It significantly decreased during NIGHT in both AMCs and SMCs (Figure 1c), and 
it increased as an effect of BB only in AMCs (Figure 1e). The CF of the first IMF computed over the 
QT series was not influenced by mutation (Figure 1b); it was not modified during NIGHT (Figure 1d), 
and it was not affected by BB (Figure 1f). It is worth noting that after pooling together the CFs 
calculated in all individuals (i.e., NMCs and MCs) regardless of the experimental period (i.e., DAY or 
NIGHT) and therapy (i.e., BBoff or BBon), the CF assessed over the HP series was significantly 
smaller than that derived from QT series.  
Figure 1. Bar and grouped bar graphs show the CF of the first IMF computed over HP and 
QT variability in (a,c,e) and (b,d,f), respectively. The series were derived from BBoff 
NMCs (gray bars), AMCs (black bars) and SMCs (white bars) during DAY in (a) and (b), 
from BBoff AMCs and SMCs during DAY and NIGHT in (c) and (d) and from AMCs and 
SMCs both BBoff and BBon during DAY in (e) and (f). Values are given as the mean plus 
standard deviation. The symbol * indicates p < 0.05.  
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Figure 2 shows SampEn computed over HP and QT variability after pooling together all individuals 
regardless of the experimental period and therapy. SampEn was computed over the original series x 
(SampEnx, with x = HP or QT, slash-pattern bars) and over the EMD-filtered version (SampEnxf, with 
x = HP or QT, backslash-pattern bars). SampEn over QT variability was significantly higher than 
SampEn over HP variability regardless of the processing (i.e., original or filtered series). SampEnx, 
was significantly higher than SampEnxf regardless of the series (i.e., HP or QT).  
Figure 2. Grouped bar graphs show results of short-term complexity analysis over HP and 
QT variability after pooling together all individuals (i.e., NMCs and MCs) regardless of the 
experimental period (i.e., DAY or NIGHT) and therapy (i.e., BBoff or BBon). SampEn 
was computed over the original series x (SampEnx, with x = HP or QT, slash-pattern bars) 
and over the EMD-filtered version (SampEnxf, with x = HP or QT, backslash-pattern bars). 
Values are given as the mean plus standard deviation. The symbol * indicates p < 0.05.  
 
Figure 3 shows SampEn computed over the beat-to-beat variability of HP (Figure 3a,b) and QT 
(Figure 3c,d) in BBoff NMCs (gray bars) and MCs during DAY. MCs were divided into AMCs (black 
bars) and SMCs (white bars). SampEn was computed over the original HP and QT series in  
Figure 3a,c, respectively, and over the EMD-filtered HP and QT versions in Figure 3b,d, respectively. 
SampEn over the original HP and QT series (Figure 3a,c) and over the EMD-filtered HP versions 
(Figure 3b) was similar in all considered groups. Conversely, SampEn computed over the  
EMD-filtered QT series distinguished AMCs from NMCs, while no difference was detected between 
NMCs and SMCs and between AMCs and SMCs (Figure 3d).  
Figure 4 shows SampEn computed over the beat-to-beat variability of HP (Figure 4a,b) and QT 
(Figure 4c,d) in BBoff MCs during DAY and NIGHT. MCs were divided into AMCs (black bars) and 
SMCs (white bars). SampEn was computed over the original HP and QT series in Figure 4a,c, 
respectively, and over the EMD-filtered HP and QT versions in Figure 4b,d, respectively. SampEn 
computed over the HP variability increased during NIGHT in both AMCs and SMCs (Figure 4a), 
while this circadian rhythm was not evident in SampEn computed over the EMD-filtered HP 
variability (Figure 4b). Conversely, while SampEn computed over the HP variability was not able to 
distinguish AMCs from SMCs during both DAY and NIGHT (Figure 4a), SampEn computed over the 
EMD-filtered HP variability differentiated AMCs and SMCs during DAY, being larger in SMCs than 
in AMCs (Figure 4b). SampEn computed over the QT variability decreased during NIGHT in both 
AMCs and SMCs (Figure 4c), while this circadian rhythm was observed in SampEn calculated over 
the EMD-filtered QT series only in SMCs (Figure 4d).  
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Figure 3. Bar graphs show the results of short-term complexity analysis over HP and QT 
variability in (a,b) and (c,d), respectively. The series were derived from BBoff NMCs 
(gray bars) and MCs during DAY. MCs were divided in AMCs (black bars) and SMCs 
(white bars). SampEn was assessed over the original series in (a) and (c) and over the 
EMD-filtered series in (b) and (d). Values are given as the mean plus standard deviation. 
The symbol * indicates p < 0.05.  
 
Figure 4. Grouped bar graphs show the results of short-term complexity analysis over HP 
and QT variability in (a,b) and (c,d), respectively. The series were derived from BBoff 
MCs during DAY and NIGHT. MCs were divided in AMCs (black bars) and SMCs (white 
bars). SampEn was assessed over the original series in (a) and (c) and over the  
EMD-filtered series in (b) and (d). Values are given as the mean plus standard deviation. 
The symbol * indicates p < 0.05.  
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Figure 5 shows SampEn computed over the beat-to-beat variability of HP (Figure 5a,b) and QT 
(Figure 5c,d) in BBoff and BBon MCs. MCs were divided into AMCs (black bars) and SMCs (white 
bars). SampEn computed over the HP variability increased BBon in both AMCs and SMCs  
(Figure 5a), while the effect of BB was not evident in SampEn computed over the EMD-filtered HP 
variability (Figure 5b). Conversely, while SampEn computed over the HP variability was not able to 
separate AMCs from SMCs both BBoff and BBon (Figure 5a), SampEn computed over the  
EMD-filtered HP variability differentiated BBoff AMCs from SMCs, being larger in BBoff SMCs 
than in BBoff AMCs (Figure 5b). SampEn computed over the QT variability was similar in AMCs and 
SMCs regardless of the administration of BB (Figure 5c). Conversely, the effect of BB was to decrease 
SampEn computed over the EMD-filtered QT variability in SMCs, while it remained unmodified in 
AMCs (Figure 5d).  
Figure 5. Grouped bar graphs show the results of short-term complexity analysis over HP 
and QT variability in (a,b) and (c,d), respectively. The series were derived from BBoff and 
BBon MCs during DAY. MCs were divided in AMCs (black bars) and SMCs (white bars). 
SampEn was assessed over the original series in (a) and (c) and over the EMD-filtered 
series in (b) and (d). Values are given as the mean plus standard deviation. The symbol * 
indicates p < 0.05.  
 
5. Discussion  
The main findings of this study are: (i) the EMD-based filtering method was helpful to cancel 
broad-band noise present on QT variability; (ii) when applied to QT variability obtained from 24-hour 
Holter recordings in LQT1 patients, the EMD-based filtering approach differentiated AMCs from 
NMCs and detected the effect of BB on SMCs; (iii) when applied to HP variability obtained from  
24-hour Holter recordings in LQT1 patients, the EMD-based filtering method cancelled the 
contribution of vagal modulation to the HP dynamics and enhanced cardiovascular control targeting 
the sinus node via inputs at frequencies slower than the breathing rate; and (iv) the comparison 
between complexity indexes derived from the EMD-filtered QT and HP series confirmed the larger 
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complexity of cardiac control directed to ventricles compared to the one targeting the sinus node as a 
likely result of inputs modifying QT independently of HP changes.  
5.1. EMD-Filtered QT Variability Allowed the Separation of AMCs from NMCs  
We have recently found that the complexity of the QT variability at long time scales, as 
automatically assessed from 24-hour Holter recordings, is smaller in AMCs than in SMCs [10]. This 
finding is clinically relevant, because it suggests that a low complexity of the sympathetic control 
directed to ventricles at long time scales, as assessed from QT variability, is a protective factor in 
LQT1, and markers of QT variability complexity can be utilized to improve risk stratification in LQT1. 
Of special interest, this result was obtained at long time scales via multiscale entropy [11,12], while 
traditional complexity analysis at short time scales failed to separate groups [10]. One possible 
explanation of the different power of the multiscale complexity indexes as a function of the time scale 
might be the presence of broad-band noise commonly affecting QT variability when automatically 
derived from 24-hour Holter recordings [13]. The multiscale entropy approach, especially at long time 
scales, has the intrinsic ability to filter out fast QT variations, thus limiting the effect of broad-band 
noise on the complexity estimates [10]. The present study tested the hypothesis that even complexity 
analysis at short time scales, carried out via the traditional estimation of SampEn, has the possibility to 
distinguish groups with different cardiac risk provided that it is computed over a suitable filtered 
version of the original QT variability series. Here, the proposed filtering procedure is based on the 
identification of the fastest IMF, as detected from EMD, and on its subtraction from the original series. 
This procedure is motivated by the observation that the EMD-filtered version of the QT variability is 
obtained without a priori setting the frequency response of the low-pass filter, because the fastest IMF 
describes the most rapid temporal scales on a case-by-case basis, thus increasing the flexibility of the 
low-pass filtering procedure. In agreement with the hypothesis, we found out that SampEn computed 
over the EMD-filtered QT variability differentiated AMCs from NMCs, while NMCs were similar to 
the SMCs. The smaller value of SampEn computed over the EMD-filtered QT variability in AMCs is 
in agreement with the findings obtained from the original QT variability at long time scales in [10] and 
confirms the observation that a low complexity of the sympathetic control directed to ventricles is 
protective in LQT1. This result is relevant, because it simplifies the extraction of entropy-based 
complexity indexes from QT variability (i.e., the multiscale entropy approach is no longer necessary) 
and favors the inclusion of these markers into risk stratification procedures.  
5.2. EMD-Filtered QT Variability Allowed the Detection of the Effect of BB  
The ability of the EMD-filtering approach to enhance features pertinent to the sympathetic control 
directed to ventricles was stressed by the assessment of the effect of BB in MCs. Indeed, before 
applying the EMD-based filtering procedure, the complexity indexes of QT variability were not able to 
detect the effect of BB. Conversely, after the application of the EMD-based filtered procedure, the 
effect of BB over SMCs appeared clearly. Indeed, BB reduced the complexity of the EMD-filtered QT 
variability, and this reduction, in addition to the prolongation of HP and the reduction of HP  
variability [3], is protective, because it makes the complexity of the sympathetic control of SMCs more 
similar to that of the AMCs [10].  
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5.3. EMD-Based Filtering Approach Cancelled Respiratory Sinus Arrhythmia from HP Variability 
The entropy-based complexity of the HP variability at short time scales is under vagal  
control [20,21,26,27]. This observation was confirmed by the results of the present study. Indeed, 
SampEn assessed over the original HP variability was significantly increased during NIGHT and in 
response to BB in both AMCs and SMCs [10]. The effect of the EMD-based filtering procedure was to 
filter out the respiratory sinus arrhythmia largely responsible for the complexity of the HP  
variability [20,21]. Indeed, SampEn assessed over the EMD-filtered HP series did not exhibit the 
circadian rhythmicity and did not vary in response to BB. This finding stresses again the ability of the 
proposed EMD-based filtering procedure to cancel fast variations present on cardiovascular variability 
series. The ability of the EMD-based filtering procedure to cancel the respiratory sinus arrhythmia was 
supported by the CF analysis. Indeed, the CF of the first IMF derived from HP variability was lower 
during NIGHT due to the slowness of the breathing rate during sleep, and the standard deviation of the 
CF was quite large due to the high inter-subject variability of the breathing frequency.  
5.4. EMD-Based Filtering of HP Variability Enhanced Cardiac Control Targeting the Sinus Node at 
Frequencies Slower Than the Respiratory One  
The most surprising result obtained from this study over the HP variability is that the EMD-based 
filtering procedure was able to enhance features of the cardiovascular control directed to the sinus node 
that otherwise would have remained unveiled. Indeed, after the subtraction of the fastest IMF from the 
original HP variability, we were able to distinguish AMCs from SMCs. Indeed, the complexity of the 
EMD-filtered HP variability was smaller in AMCs than in SMCs during DAY in absence of BB. This 
result confirms and extends over the HP variability the observation that a smaller complexity of the 
sympathetic control is a protective factor in LQT1.  
5.5. Comparison between Complexity of EMD-Filtered HP and QT Variability  
We confirm here that QT variability is more complex than HP variability [10,28]. This finding was 
not surprising, because QT variability is more affected by broad-band noise resulting from jitters in 
delineation of the T-wave offset [24] than HP series. The analysis of the CF of the first IMF derived 
from QT variability confirmed the intrinsic noisy nature of the QT series compared to the HP one. 
Indeed, the CF computed over the QT series was higher than that derived from HP series; it was 
characterized by a lower standard deviation, and it did not vary during NIGHT. It is less trivial to find 
out that, after canceling the fastest IMF estimated via EMD, the complexity of EMD-filtered QT series 
remained significantly larger than that of the EMD-filtered HP one. Therefore, we confirm with this 
analysis the larger complexity of the cardiac control targeting QT compared to that of the cardiac 
regulation directed to the sinus node. This larger complexity might be the result of inputs capable of 
modifying QT independently of HP variations and, thus, operating in an asynchronous way with 
respect to those changing QT through modifications of HP [29–31].  
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6. Conclusions  
We proposed an EMD-based filtering procedure to improve the signal-to-noise ratio of QT 
variability series derived automatically from 24-hour Holter recordings. This procedure is particularly 
helpful before assessing entropy-based QT variability complexity at short time scales due to the large 
amount of noise usually affecting this measurement. In the proposed application to a LQT1 population 
with the founder effect, the procedure allowed the differentiation of AMCs from NMCs and the 
detection of the effect of BB in SMCs. It is remarkable that this differentiation was not achieved using 
a largely utilized clinical index, such as QTc. Since similar results were obtained at longer time scales 
using multiscale entropy analysis in [10], the practical advantage of the proposed methodology was the 
reduction of the analysis time and approach involvedness, thus favoring the application of complexity 
indexes into clinically-oriented protocols. Given the generality of the proposed EMD-based filtering 
procedure, it can be applied to any variability series characterized by a low signal-to-noise ratio due to 
jitters in the detection of the fiducial points. Therefore, we suggest to exploit this technique even 
before computing complexity indexes at short time scales from the HP series when the small size of 
the autonomic modulation leads to negligible HP changes (e.g., in the heart failure population, heart 
transplanted patients or after administration of a high dose of atropine in healthy individuals). 
However, this procedure can be profitably exploited even when the HP series is characterized by a 
high signal-to-noise ratio. In this situation, it cancels the respiratory sinus arrhythmia, thus enhancing 
features of the cardiovascular control that otherwise might remain unveiled by the dominant vagal 
modulation. Future studies should check different filtering approaches and entropy-based metrics to 
better understand the efficacy of the proposed technique compared to techniques exploiting diverse 
tools. In addition, since a possible limitation of the present study is the low sampling rate of the 
electrocardiogram, we advocate studies assessing its influence over QT variability and derived 
complexity parameters. 
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LQT1  long QT syndrome type 1 
HP  heart period  
QT  interval from Q-wave onset to T-wave end 
QTc  corrected QT  
MC  mutation carrier  
NMC  non-mutation carrier  
AMC  asymptomatic MC 
SMC  symptomatic MC 
DAY  daytime 
NIGHT  nighttime 
BB  beta-blocker therapy 
BBoff  off BB 
BBon  on BB 
EMD  empirical mode decomposition 
IMF  intrinsic mode function 
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SampEn  sample entropy 
μHP  HP mean 
μQT  QT mean 
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